Naslov
Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update

Autori
Roguljić, Hrvoje ; Ninčević, Vjera ; Bojanić, Kristina ; Kuna, Lucija ; Smolić, Robert ; Včev, Aleksandar ; Primorac, Dragan ; Včeva, Andrijana ; Wu, George Y ; Smolić, Martina

Izvornik
Frontiers in pharmacology (1663-9812) 12 (2021); 678546, 7

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
hepatitis C virus, direct antiviral agents, cardiovascular disease, diabetes mellitus, dyslipidemi

Sažetak
Hepatitis C virus (HCV) infection is a systemic disease associated with multiple significant extrahepatic manifestations. Emerging studies indicate association between the HCV infection and a higher incidence of major adverse cardiovascular events such as: coronary artery disease, heart failure, stroke and peripheral artery disease, when compared to general population. Atherosclerosis is a common pathophysiologic mechanism of cardiovascular disease (CVD) development which is the leading cause of mortality in the Western world. Proposed mechanisms of HCV- induced atherosclerosis includes systemic inflammation due to the chronic infection with increased levels of proatherogenic cytokines and chemokines. Furthermore, it has been demonstrated that HCV exists and replicates within atheroschlerotic plaques, supporting the theory of direct pro-atherogenic effect of the virus. Direct acting antiviral agents (DAAs) represent a safe and highly effective treatment of HCV infection. Beside the improvement in liver-related outcomes, DAAs exhibit a beneficial effect on extra-hepatic manifestations of chronic HCV infection. Recently, it has been shown that patients with chronic HCV infection treated with DAA-based therapeutic regimes had a 43% reduction of CVD events incidence risk. Moreover, eradication of HCV with DAAs results in a significant positive effect on risk factors for cardiovascular disease, despite a general worsening of the lipid profile. This positive effects is mainly due to an improvement of endothelial function and glucose metabolism. Although DAA treatment is associated with a beneficial impact on cardiovascular events, further studies are needed to fully elucidate the mechanisms responsible

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA